These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16639080)

  • 21. BRCA1 interacts with and is required for paclitaxel-induced activation of mitogen-activated protein kinase kinase kinase 3.
    Gilmore PM; McCabe N; Quinn JE; Kennedy RD; Gorski JJ; Andrews HN; McWilliams S; Carty M; Mullan PB; Duprex WP; Liu ET; Johnston PG; Harkin DP
    Cancer Res; 2004 Jun; 64(12):4148-54. PubMed ID: 15205325
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The inhibition of Aurora A abrogates the mitotic delay induced by microtubule perturbing agents.
    Wysong DR; Chakravarty A; Hoar K; Ecsedy JA
    Cell Cycle; 2009 Mar; 8(6):876-88. PubMed ID: 19221504
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition of BRCA1 leads to increased chemoresistance to microtubule-interfering agents, an effect that involves the JNK pathway.
    Lafarge S; Sylvain V; Ferrara M; Bignon YJ
    Oncogene; 2001 Oct; 20(45):6597-606. PubMed ID: 11641785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Role of BRCA1 in cellular resistance to paclitaxel and ionizing radiation in an ovarian cancer cell line carrying a defective BRCA1.
    Zhou C; Smith JL; Liu J
    Oncogene; 2003 Apr; 22(16):2396-404. PubMed ID: 12717416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cyclin B1 stability is increased by interaction with BRCA1, and its overexpression suppresses the progression of BRCA1-associated mammary tumors.
    Choi EK; Lim JA; Kim JK; Jang MS; Kim SE; Baek HJ; Park EJ; Kim TH; Deng CX; Wang RH; Kim SS
    Exp Mol Med; 2018 Oct; 50(10):1-16. PubMed ID: 30327455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. SIRT2 downregulation confers resistance to microtubule inhibitors by prolonging chronic mitotic arrest.
    Inoue T; Nakayama Y; Yamada H; Li YC; Yamaguchi S; Osaki M; Kurimasa A; Hiratsuka M; Katoh M; Oshimura M
    Cell Cycle; 2009 Apr; 8(8):1279-91. PubMed ID: 19282667
    [TBL] [Abstract][Full Text] [Related]  

  • 27. AURORA-A amplification overrides the mitotic spindle assembly checkpoint, inducing resistance to Taxol.
    Anand S; Penrhyn-Lowe S; Venkitaraman AR
    Cancer Cell; 2003 Jan; 3(1):51-62. PubMed ID: 12559175
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential sensitivity of BRCA1-mutated HCC1937 human breast cancer cells to microtubule-interfering agents.
    Tassone P; Blotta S; Palmieri C; Masciari S; Quaresima B; Montagna M; D'Andrea E; Eramo OP; Migale L; Costanzo F; Tagliaferri P; Venuta S
    Int J Oncol; 2005 May; 26(5):1257-63. PubMed ID: 15809716
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mad2 and BubR1 modulates tumourigenesis and paclitaxel response in MKN45 gastric cancer cells.
    Bargiela-Iparraguirre J; Prado-Marchal L; Pajuelo-Lozano N; Jiménez B; Perona R; Sánchez-Pérez I
    Cell Cycle; 2014; 13(22):3590-601. PubMed ID: 25483095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. BRCA1 suppresses the expression of survivin and promotes sensitivity to paclitaxel through the calcium sensing receptor (CaSR) in human breast cancer cells.
    Promkan M; Liu G; Patmasiriwat P; Chakrabarty S
    Cell Calcium; 2011 Feb; 49(2):79-88. PubMed ID: 21296416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Chromosomal instability, colorectal cancer and taxane resistance.
    Swanton C; Tomlinson I; Downward J
    Cell Cycle; 2006 Apr; 5(8):818-23. PubMed ID: 16628000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Carboplatin and taxol resistance develops more rapidly in functional BRCA1 compared to dysfunctional BRCA1 ovarian cancer cells.
    Busschots S; O'Toole S; O'Leary JJ; Stordal B
    Exp Cell Res; 2015 Aug; 336(1):1-14. PubMed ID: 25499884
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of BRCA1 and BRCA2 expression in human breast cancer cells by DNA-damaging agents.
    Andres JL; Fan S; Turkel GJ; Wang JA; Twu NF; Yuan RQ; Lamszus K; Goldberg ID; Rosen EM
    Oncogene; 1998 Apr; 16(17):2229-41. PubMed ID: 9619832
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Inhibition of TRIP1/S8/hSug1, a component of the human 19S proteasome, enhances mitotic apoptosis induced by spindle poisons.
    Yamada HY; Gorbsky GJ
    Mol Cancer Ther; 2006 Jan; 5(1):29-38. PubMed ID: 16432160
    [TBL] [Abstract][Full Text] [Related]  

  • 35. BRCA1-IRIS activates cyclin D1 expression in breast cancer cells by downregulating the JNK phosphatase DUSP3/VHR.
    Hao L; ElShamy WM
    Int J Cancer; 2007 Jul; 121(1):39-46. PubMed ID: 17278098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tamoxifen-resistant breast cancer cells are resistant to DNA-damaging chemotherapy because of upregulated BARD1 and BRCA1.
    Zhu Y; Liu Y; Zhang C; Chu J; Wu Y; Li Y; Liu J; Li Q; Li S; Shi Q; Jin L; Zhao J; Yin D; Efroni S; Su F; Yao H; Song E; Liu Q
    Nat Commun; 2018 Apr; 9(1):1595. PubMed ID: 29686231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. p53 deficiency and defective mitotic checkpoint in proliferating T lymphocytes increase chromosomal instability through aberrant exit from mitotic arrest.
    Baek KH; Shin HJ; Yoo JK; Cho JH; Choi YH; Sung YC; McKeon F; Lee CW
    J Leukoc Biol; 2003 Jun; 73(6):850-61. PubMed ID: 12773518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Paclitaxel targets FOXM1 to regulate KIF20A in mitotic catastrophe and breast cancer paclitaxel resistance.
    Khongkow P; Gomes AR; Gong C; Man EP; Tsang JW; Zhao F; Monteiro LJ; Coombes RC; Medema RH; Khoo US; Lam EW
    Oncogene; 2016 Feb; 35(8):990-1002. PubMed ID: 25961928
    [TBL] [Abstract][Full Text] [Related]  

  • 39. BRCA1 and GADD45 mediated G2/M cell cycle arrest in response to antimicrotubule agents.
    Mullan PB; Quinn JE; Gilmore PM; McWilliams S; Andrews H; Gervin C; McCabe N; McKenna S; White P; Song YH; Maheswaran S; Liu E; Haber DA; Johnston PG; Harkin DP
    Oncogene; 2001 Sep; 20(43):6123-31. PubMed ID: 11593420
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Paclitaxel Sensitivity of Ovarian Cancer Can be Enhanced by Knocking Down Pairs of Kinases that Regulate MAP4 Phosphorylation and Microtubule Stability.
    Yang H; Mao W; Rodriguez-Aguayo C; Mangala LS; Bartholomeusz G; Iles LR; Jennings NB; Ahmed AA; Sood AK; Lopez-Berestein G; Lu Z; Bast RC
    Clin Cancer Res; 2018 Oct; 24(20):5072-5084. PubMed ID: 30084832
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.